Access to the PDF text

Archives of cardiovascular diseases
Volume 106, n° 5
pages 274-286 (mai 2013)
Doi : 10.1016/j.acvd.2013.02.005
Received : 5 December 2012 ;  accepted : 28 February 2013
Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010
Fréquences des traitements médicamenteux anti-hypertenseurs, antidiabétiques et hypolipémiants en France en 2010

Figure 1

Figure 1 : 

Regional treatment frequencies for cardiovascular risk factors* and combinations of risk factors among general scheme beneficiaries in 2010, adjusted for age and sex. *A patient treated for hypertension and diabetes was counted in hypertension, diabetes and hypertension–diabetes.

Figure 2

Figure 2 : 

Proportion of general scheme beneficiaries treated for a given risk factor and also receiving treatment for other risk factors in 2010, according to the presence or absence of cardiovascular disease, according to age. *Coronary heart disease and myocardial infarction, stroke and peripheral artery disease. HL: hyperlipidaemia; HT: hypertension.

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline